HALEY STUART: Open Payments
NPI 1437798733 · HARTSELLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 87 payments from 25 companies in 2025. Trend: 2023 $1,727 · 2024 $1,839 · 2025 $1,680
Food & beverage: $1,680
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| AstraZeneca Pharmaceuticals LP | 7 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $154 |
| Amgen Inc. | 9 | $140 |
| Corcept Therapeutics | 4 | $99 |
| Novo Nordisk Inc | 4 | $90 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| PFIZER INC. | 5 | $81 |
| Lilly USA, LLC | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
Products named: CAPLYTA, REXULTI, UBRELVY, Korlym, OTEZLA, LEQVIO, JARDIANCE, VRAYLAR.
Industry payments across AL — which companies pay providers there.
